Evofem Biosciences, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2009-01-01
- Employees
- 51
- Market Cap
- $1M
- Website
- http://www.evofem.com
Clinical Trials
7
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
- Conditions
- Sexually Transmitted DiseasesGonorrheaChlamydia
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 1892
- Registration Number
- NCT04553068
- Locations
- 🇺🇸
Cahaba Medical Care, Birmingham, Alabama, United States
🇺🇸Mobile Obstetrics & Gynecology, P.C., Mobile, Alabama, United States
🇺🇸Marchand OBGYN, Mesa, Arizona, United States
AMP002 Phase III Contraceptive Study
- First Posted Date
- 2017-08-09
- Last Posted Date
- 2020-09-17
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 1384
- Registration Number
- NCT03243305
- Locations
- 🇺🇸
Coastal Clinical Research, Inc., Mobile, Alabama, United States
🇺🇸East Valley Family Physicians 137, Chandler, Arizona, United States
🇺🇸Mesa Obstetricians & Gynecologists 184, Mesa, Arizona, United States
Phase 2B/3 Double-blinded Placebo-controlled
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 860
- Registration Number
- NCT03107377
- Locations
- 🇺🇸
Coastal Clinical Research, Inc., Mobile, Alabama, United States
🇺🇸Mobile OB-GYN, PC, Mobile, Alabama, United States
🇺🇸MedPharmics, LLC, Phoenix, Arizona, United States
Duration of Effect of Acidform Gel on Vaginal pH
- Conditions
- Healthy
- Interventions
- Drug: Acidform 5 gDrug: Acidform 4 gDrug: Placebo 4 gDrug: Acidform 3 g
- First Posted Date
- 2016-02-26
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT02693418
- Locations
- 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸Metro Health Medical Center, Cleveland, Ohio, United States
Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2019-12-10
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT02483533
- Prev
- 1
- 2
- Next